LabGenius, the company that’s using machine learning for the development of protein therapeutics, has raised an additional $10M in Series A funding from investors that include Felicis Ventures, Lux Capital, Inovia Capital, Obvious Ventures, Patrick Pichette, Air Street Capital, and Chris Gibson. Founded by Harry Rickerby, James Field, and Rhys Algar in 2012, LabGenius has now raised a total of $13.7M in reported equity funding.
The TechWatch Media Group audience is driving progress and innovation on a global scale. TechWatch Media is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a report like this. Find out more here.
